Araştırma Makalesi

The Effect Of Ankaferd Blood Stopper As A Drug On Human Umbilical Vein Endothelial Cell Culture (Huvec)

- , 01.12.2019
https://doi.org/10.16919/bozoktip.469448

Öz

ÖZET



Giriş: Ankaferd
kan stoper (ABS) folklorik tıbbi bitki ekstraksiyonudur. Ülkemizde yıllardır
geleneksel hemostatik ajan olarak kullanılmaktadır. ABS Thymus vulgaris,
Glicirhiza glabra, Vitis vinifera, Alpinia officinarum ve Urtica dioica
bitkilerinin standardize edilmiş bir karışımıdır. Bu bitkilerin hepsinin
bireysel olarak endotel, kan hücreleri, anjiogenez, hücre proliferasyonu,
vasküler dinamikler ve mediatörler üzerine etkisinin olabileceği rapor
edilmiştir. Bu çalışmanın amacı in vitro endotel hücre çoğalmasının ABS'nin
farklı zaman ve dozlarının in vitro apoptotik etkilerini araştırmaktır.



Gereç
ve yöntem:
Erciyes Üniversitesi hastanesinde
sezeryanla yapılan doğumlardan alınan göbek bağı toplardamarı PBS ile yıkandıktan sonra içine yaklaşık 10 mg/ml kollajenaz verildi ve 10 dakika 37ºC de
inkübatörde bekletildi. Damar içerisindeki hücre ve kollajenaz karışımı tüp
içine alındıktan ve 30 ml besi yeri ilave edildikten sonra 1000 rpm’de 10
dakika santrifüj edildi. Üstteki supernatant atıldı ve tüpün dip kısmında
biriken hücreler üzerine 2 ml besi yeri ilave edilerek karıştırıldı ve 25
cm’lik flasklara ekildi. Ekilen hücreler konfluense ulaşınca pasajlama yapıldı.
Yeterince hücre elde edildikten sonra Thoma lamında sayılan hücreler gruplara
ayrıldı. Her bir gruba ait kültür ortamına sırasıyla
5 µl, 25
µl and 50 µl ABS
24 saat süre ile uygulanmıştır. 24 saat
sonra hücreler tripsin/EDTA ile muamele edildi. Hücreler tripan mavisi ile
boyandı ve ışık mikroskobu altında canlı hücreler Thoma lamında sayılarak fotoğrafları
çekildi. Daha sonra hücrelerin canlılığı ve/veya proliferasyonu MTS testii ile
tespit edildi.



Bulgular:
HUVEC‟lere ABS muamelesi boyunca, mikroskobik olarak hücrelerin yüzeyden
kalktığı ve birbirlerine yapıştığı ve 24 saat sonra ise normal büyümelerine ve
fonkiyonlarına döndükleri gözlemlenmiştir. Doza bağlı olarak deney grubu
hücrelerinde bir artışın olduğu görüldü. Kontrol ve deney gruplarından elde
edilen ortalama hücre sayısı sırasıyla
7,68x103
(±1,7), 5,56x103(±1,09) 4,12x103(±1,14) ve 2,43x103(±0,89)
idi.
Deney gruplarının kontrol grubu ile karşılaştırıldığında deney gruplarındaki
azalma istatistiksel olarak anlamlıydı (p <0,05). Deney grupları (5 µl, 25
µl ve 50 µl ABS), HUVEC'de yüksek dozda bağlı olarak birbiri ile karşılaştırıldığında
azalmış bir hücre sayısı göstermiş ve istatistiksel olarak anlamlı bulundu (p
<0.05). Ayrıca, regresyon analizinin sonuçları hücre canlılığının doza bağlı
olarak azaldığını, yani dozun artmasıyla hücre ölümünün arttığını gösterdi.



Sonuç:
Çalışmamızda ABS'nin apoptotik etkisi HUVEC'de gösterildi. Apoptoz, bir hücrede
gerçekleşen biyokimyasal, morfolojik ve moleküler değişikliklerden
yararlanılarak çeşitli yöntemler aracılığı ile ölçülebilir. ABS'nin apoptotik
etkisi, kanser hastalıklarının tedavisinde alternatif bir yol olabileceğini
göstermektedir.



Abstract



Introduction: Ankaferd Blood Stopper (ABS) is an herbal extract which has
been used historically as a haemostatic agent in traditional Turkish medicine.
ABS comprises of standardized mixture of herbs T. vulgaris, G. glabra, V.
vinifera, A. officinarum and U. dioica. Basic effect mechanism of ABS is the
formation of an encapsulated protein web which represents the focus points for
the vital erythrocyte masses. The haemostatic effects have been demonstrated by
in vitro and in vivo studies. The aim of this study was to investigate the in
vitro apoptotic effects of the different times and doses of ABS on in vitro
endothelial cell proliferation.



Methods:
Human
umbilical cord obtained at Caesarean sections from Erciyes University hospital.
After washing PBS, the cord vein lumen was filled with PBS containing 10 mg/ml
collagenase and incubated 10 minute at 37°C. The contents of the vein were gently
flushed out with an equal volume of 30 ml medium collected in a conical
centrifuge tube then centrifugated at 1000 rpm for 10 minute yielded a small
white pellet which was resuspended in culture medium. The cells were plated in
2 ml of medium at T-25 plastic flasks. The endothelial cells were passaged when
confluent density was approached. The endothelial cells were incubated with
only medium in control group and different concentrations of ABS (5 µl, 25 µl
and 50 µl ABS) in the experimental groups for 24 h. After 24 hours the cells
were then detached with tripsin/EDTA solution. Cells were stained with trypan
blue and viable cells were counted with hemocytometer under the light
microscope then photographs were taken of the process steps.
Then the viability
and/or proliferation of cells were detected by MTS assay.



Results: The mean cell number were obtained from the control
and experimental groups 7,68x103 (±1,7), 5,56x103(±1,09)
4,12x103(±1,14), and 2,43x103(±0,89) respectively. The
cells of the experimental groups compared with the control group to the
decrease in experimental groups was statistically significant (p<0,05).
Experimental groups (
5 µl, 25 µl and 50 µl ABS) were showed a decreased cell number in HUVEC
compared with the each other depended on high dose and was found to be
statistically significant  (p<0.05).
Furthermore, the results of regression analysis showed that cell viability was
decreased depending on the dose, that was, the cell death was increased as the
dose was increased.



Conclusion: In our study, the apoptotic effect of ABS was investigated
in HUVEC. The apoptosis can be measured using various of methods by taking
advantage of the biochemical, morphological, and molecular changes undergoing
in a cell during this process. The apoptotic effect of ABS shows that it may be
an alternative way of treating cancer diseases.

Kaynakça

  • Referans 1. Dinçol ME, Ozbas H, Yılmaz B, Ersev H, Gokyay S and Olgac V. Effect of the plant-based hemostatic agent Ankaferd Blood Stopper on the biocompatibility of mineral trioxide aggregate. BMC Oral Health 2016; 16: 111.
  • Referans 2. Beyazit Y, Kurt M, Kekilli M, Goker H, Haznedaroglu İC. Evaluation of Hemostatic Effects of Ankaferd as an Alternative Medicine. Altern Med Rev 2010; 15(4): 329-336.
  • Referans 3. Huri E, Haznedaroglu IC, Akgul T, Astarci M, Ustun H, Germiyanoulu C. Biphasic effects of ankaferd blood stopper on renal tubular apoptosis in the rat partial nephrectomy model representing distinct levels of hemorrhage. Saudi Med J. 2010; 31(8): 864-8.
  • Referans 4. Yılmaz E, Güleç Ş, Torun D, Haznedaroğlu İC, Akar N. The effects of Ankaferd Blood Stopper on transcription factors in HUVEC and the erythrocyte protein profile. Turk J Hematol 2011; 28: 276-85.
  • Referans 5. Arslan S, Haznedaroglu IC, Oz B, Goker H. Endobronchial application of Ankaferd blood stopper to control profuse lung bleeding leading to hypoxemia and hemodynamic instability. Respiratory Medicine 2009; 2: 144-6.
  • Referans 6. Kurt M, Akdogan M, Onal IK, Kekilli M, Arhan M, Aksu S, Kurt OK, Haznedaroglu IC. Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: a retrospective analysis. Dig Liver Dis 2010; 42: 196-9.
  • Referans 7. Lang I, Pabst M.A, Hiden U, Blaschitz A., Dohr G, Hahn T, Desoye G. Heterogeneity of microvascular endothelial cells isolated from human term placenta and macrovascular umbilical vein endothelial cells. Eur J Cell Biol 2003; 82(4): 163–173.
  • Referans 8. Ribatti D, Nico B, Vacca A, Roncali L, Dammacco F. Endothelial cell heterogeneity and organ specificity. J Hemototherap Stem Cell Res 2002; 11: 81–90.
  • Referans 9. Aird, W.C. Phenotypich heterogeneity of the endothelium: I.Structure, function, and mechanisms. Circ Res 2007; 100: 158–173.
  • Referans 10. Schechner JS, Nath AK, Zheng L, et al. In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. Proc Natl Acad Sci USA 2000: 97: 9191–9196.
  • Referans 11. Zheng L, Dengler TJ, Kluger MS, et al. Cytoprotection of human umbilical vein endothelial cells against apoptosis and CTL mediated lysis provided by caspase-resistant Bcl-2 without alterations in growth or activation responses. J Immunol, 2000; 164: 4665–4671.
  • Referans 12. Enis DR, Shepherd BR, Wang Y, et al. Induction, differentiation, and remodeling of blood vessels after transplantation of Bcl-2-transduced endothelial cells. Proc Natl Acad Sci USA 2005; 102: 425–430.
  • Referans 13. Levenberg S, Rouwkema J, Macdonald M, et al. Engineering vascularized skeletal muscle tissue. Nat Biotechnol 2005; 23: 879–884.
  • Referans 14. Kelm JM, Djonov V, Hoerstrup SP, et al. Tissue-transplant fusion and vascularization of myocardial microtissues and macrotissues implanted into chicken embryos and rats. Tissue Eng 2006; 12: 2541–2553.
  • Referans 15. Shepherd BR, Enis DR, Wang F, Suarez Y, Pober JS, Schechner JS. Vascularization and engraftment of a human skin substitute using circulating progenitor cell-derived endothelial cells. FASEB J 2006; 1739–1741.
  • Referans 16. Rouwkema J, De Boer J, Van Blitterswijk CA. Endothelial cells assemble into a 3-dimensional prevascular network in a bone tissue engineering construct. Tissue Eng 2006; 12: 2685–2693.
  • Referans 17. Mihmanli A, Ulker Z, Alpsoy L, Ezirganli S. Evaluation of cytotoxicity of a new hemostatic agent Ankaferd blood stopper using different assays. Hum Exp Toxicol 2012; 31: 780-787.
  • Referans 18. Turhan N, Kurt M, Shorbagi A, et al. Topical Ankaferd Blood Stopper administration to bleeding gastrointestinal carcinomas decreases tumor vascularization. Am J Gastroenterol 2009; 104: 2874-2877.
  • Referans 19. Ozaslan E, Purnak T, Yildiz A, et al. The effect of Ankaferd Blood Stopper on severe radiation colitis. Endoscopy 2009; 41: E321-E322.
  • Referans 20. Shorbagi A, Sivri B. Successful management of a difficult case of radiation proctopathy with Ankaferd Blood Stopper: a novel indication (with video). Gastrointest Endosc 2010; 72: 666-667.
  • Referans 21. Akalin I, Okur FV, Haznedaroglu IC, et al. Acute in vitro effects of ABS (Ankaferd hemostat) on the lymphoid neoplastic cells (B-CLL and RAJI tumor cell lines). UHOD 2014; 24(4): 253–259.
  • Referans 22. Mumcuoglu M, Akin DF, Ezer U, et al. Ankaferd Blood Stopper induces apoptosis and regulates PAR1 and EPCR expression in human leukemia cells. Egypt J Med Human Gen 2015; 16(1): 19–27.
  • Referans 23. Odabas ME, Erturk M, Cinar C, et al. Cytotoxicity of a new hemostatic agent on human pulp fibroblasts in vitro. Med Oral Patol Oral Cir Bucal 2011; 16(4): e584–e587.
  • Referans 24. Haznedaroglu BZ, Beyazit Y, Walker SL, et al. Pleiotropic cellular, hemostatic, and biological actions of Ankaferd hemostat. Crit Rev Oncol Hematol 2012; 83(1): 21–34.
  • Referans 25. Turk S, Malkan UY, Ghasemi M, Hocaoglu H, Mutlu D, Gunes G, Aksu S and Haznedaroglu IC. Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines. SAGE Open Medicine 2017; 5: 1–7.
  • Referans 26. Kocyigit A, Guler EM, Haznedaroglu İC, and Malkan UY. Ankaferd hemostat induces DNA damage, apoptosis and cytotoxic activity by generating reactive oxygen species in melanoma and normal cell lines. Int J Clin Exp Med 2017; 10(2): 2116-2126.
  • Referans 27. Aktaş B, Başar O, Yılmaz B, Ekiz F, Altınbaş A,Coban S, Büyükçam F, Albayrak A, Giniş Z, Yüksel O, Delibaşı T. Serum M30 and M65 levels and effects of Ankaferd blood stopper in cerulein induced experimental acute pancreatitis model in rats. Int J Clin Exp Med 2014; 7: 1676.
  • Referans 28. Isler SC, Demircan S, Cakarer S, et al. Effects of folk medicinal plant extract Ankaferd Blood Stopper on early bone healing. J Appl Oral Sci 2010; 18: 409–414.
Toplam 28 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Yazarlar

Mehtap Nisari

Harun Ülger

Yasemin Torun Bu kişi benim

Mehmet Akif Özdemir Bu kişi benim

Zuhal Hamurcu Bu kişi benim

Yayımlanma Tarihi 1 Aralık 2019

Kaynak Göster

APA Nisari, M., Ülger, H., Torun, Y., Özdemir, M. A., vd. (t.y.). The Effect Of Ankaferd Blood Stopper As A Drug On Human Umbilical Vein Endothelial Cell Culture (Huvec). Bozok Tıp Dergisi. https://doi.org/10.16919/bozoktip.469448
AMA Nisari M, Ülger H, Torun Y, Özdemir MA, Hamurcu Z. The Effect Of Ankaferd Blood Stopper As A Drug On Human Umbilical Vein Endothelial Cell Culture (Huvec). Bozok Tıp Dergisi. doi:10.16919/bozoktip.469448
Chicago Nisari, Mehtap, Harun Ülger, Yasemin Torun, Mehmet Akif Özdemir, ve Zuhal Hamurcu. “The Effect Of Ankaferd Blood Stopper As A Drug On Human Umbilical Vein Endothelial Cell Culture (Huvec)”. Bozok Tıp Dergisit.y. https://doi.org/10.16919/bozoktip.469448.
EndNote Nisari M, Ülger H, Torun Y, Özdemir MA, Hamurcu Z The Effect Of Ankaferd Blood Stopper As A Drug On Human Umbilical Vein Endothelial Cell Culture (Huvec). Bozok Tıp Dergisi
IEEE M. Nisari, H. Ülger, Y. Torun, M. A. Özdemir, ve Z. Hamurcu, “The Effect Of Ankaferd Blood Stopper As A Drug On Human Umbilical Vein Endothelial Cell Culture (Huvec)”, Bozok Tıp Dergisi, doi: 10.16919/bozoktip.469448.
ISNAD Nisari, Mehtap vd. “The Effect Of Ankaferd Blood Stopper As A Drug On Human Umbilical Vein Endothelial Cell Culture (Huvec)”. Bozok Tıp Dergisi. t.y. https://doi.org/10.16919/bozoktip.469448.
JAMA Nisari M, Ülger H, Torun Y, Özdemir MA, Hamurcu Z. The Effect Of Ankaferd Blood Stopper As A Drug On Human Umbilical Vein Endothelial Cell Culture (Huvec). Bozok Tıp Dergisi. doi:10.16919/bozoktip.469448.
MLA Nisari, Mehtap vd. “The Effect Of Ankaferd Blood Stopper As A Drug On Human Umbilical Vein Endothelial Cell Culture (Huvec)”. Bozok Tıp Dergisi, doi:10.16919/bozoktip.469448.
Vancouver Nisari M, Ülger H, Torun Y, Özdemir MA, Hamurcu Z. The Effect Of Ankaferd Blood Stopper As A Drug On Human Umbilical Vein Endothelial Cell Culture (Huvec). Bozok Tıp Dergisi.
Copyright © BOZOK Üniversitesi - Tıp Fakültesi